Merck KGaA agreed to sell its CDMO business as part of a plan to focus on innovation-driven businesses. The business is described as entering its next growth phase under Lonza, and no sale price or effect on Merck's sales or profit is given, so the story does not establish how the sale changes Merck's prospects.
The sale fits Merck KGaA's stated plan to focus on innovation-driven businesses. But the CDMO business is described as entering its next growth phase under Lonza. The story gives no sale price or effect on Merck's sales or profit, so it does not establish how the sale changes Merck's business prospects.
Follow Merck KGaA (MRK) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MRK